SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Molina Healthcare, Inc. – ‘8-K’ for 8/10/22

On:  Wednesday, 8/10/22, at 4:24pm ET   ·   For:  8/10/22   ·   Accession #:  1179929-22-120   ·   File #:  1-31719

Previous ‘8-K’:  ‘8-K’ on / for 7/27/22   ·   Next:  ‘8-K’ on / for 8/17/22   ·   Latest:  ‘8-K’ on 9/26/22 for 9/23/22

Magnifying glass tilted right emoji
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 8/10/22  Molina Healthcare, Inc.           8-K:7,9     8/10/22   11:224K

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     35K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     12K 
 6: R1          Cover Page Document                                 HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     11K 
 7: XML         XBRL Instance -- moh-20220810_htm                    XML     21K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- moh-20220810_lab                      XML     67K 
 5: EX-101.PRE  XBRL Presentations -- moh-20220810_pre               XML     33K 
 3: EX-101.SCH  XBRL Schema -- moh-20220810                          XSD     10K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
11: ZIP         XBRL Zipped Folder -- 0001179929-22-000120-xbrl      Zip     18K 

‘8-K’   —   Current Report

This is an HTML Document rendered as filed.  [ Alternative Formats ]

 iX:   C:  C: 
 i 0001179929 i false00011799292022-08-102022-08-10

Washington, D.C. 20549
FORM  i 8-K
Current Report
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 10, 2022 ( i August 10, 2022)
(Exact name of registrant as specified in its charter)
 i Delaware i 1-31719 i 13-4204626
(State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
 i 200 Oceangate, Suite 100, i Long Beach, i California i 90802
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: ( i 562)  i 435-3666
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 i  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
 i Common Stock, $0.001 Par Value  i MOH i New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.

Item 7.01.    Regulation FD Disclosure.
On August 10, 2022, the Company announced that its Mississippi health plan subsidiary has been notified by the Mississippi Division of Medicaid (DOM) of its intent to award a Medicaid Coordinated Care Contract for its Mississippi Coordinated Access Program (MississippiCAN) and Mississippi Children’s Health Insurance Program (CHIP) pursuant to the Request for Qualifications issued by DOM on December 10, 2021. The full text of the press release is included as Exhibit 99.1 to this report.

Note: The information in this Form 8-K and the exhibits attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01.    Financial Statements and Exhibits.
(d)     Exhibits:
Exhibit No.Description
Cover Page information from Molina Healthcare, Inc.’s Current Report on Form 8-K filed on August 10, 2022 formatted in iXBRL (Inline Extensible Business Reporting Language).

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
August 10, 2022
/s/ Jeff D. Barlow
Jeff D. Barlow
Chief Legal Officer and Secretary

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:8/10/22None on these Dates
 List all Filings 
Filing Submission 0001179929-22-000120   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2022 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Sep. 27, 9:04:28.1pm ET